SCIENCE@home

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

M. Carbone,A. Penna,C. Mazzarelli,E. Martin,C. Villard,A. Bergquist,P. Line,J. Neuberger,S. Al-Shakhshir,P. Trivedi,U. Baumann,L. Cristoferi,J. Hov,B. Fischler,N. Hadžić,D. Debray,L. Antiga,N. Selzner,L. Belli,S. Nadalin,D. Penna,De Mazzarelli C,J. Neuberger,Cristoferi L Hov J Fischler B Hadzic NH Debray D D ’ Antiga L Trivedi PJ Baumann U

Published 2023 in Transplant International

ABSTRACT

Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD) and a lead indication for liver transplantation (LT) in the western world. In this article, we present a Consensus Statement on LT practice, developed by a dedicated Guidelines’ Taskforce of the European Society of Organ Transplantation (ESOT). The overarching goal is to provide practical guidance on commonly debated topics, including indications and timing of LT, management of bile duct stenosis in patients on the transplant waiting list, technical aspects of transplantation, immunosuppressive strategies post-transplant, timing and extension of intestinal resection and futility criteria for re-transplantation.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-100 of 122 references · Page 1 of 2

12
Next

CITED BY

Showing 1-27 of 27 citing papers · Page 1 of 1